MCL1 and laryngeal neoplasm: Next, we examined the expression of BCL-2, BCL-XL, and MCL-1 in TMAs comprising tissue obtained from 191 SCCHN patients at the time of surgery, from oral cavity, hypopharyngeal and laryngeal tumors.